UniProt/SwissProt ID: | KI2L1_HUMAN |
Description: | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 [Source:HGNC Symbol;Acc:6329] |
Location: | chr19 q13.42 |
Node attribute: | receptor |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T311 | NHCVFtQRKIT | PhosphoSitePlus | |
Y302 | PQEVTyTQLNH | PhosphoSitePlus | |
Y332 | TDIIVyTELPN | PhosphoSitePlus | |
T180 | PKVNGtFQADF | ig | PhosphoSitePlus |
S281 | VMDQEsAGNRT | PhosphoSitePlus | |
Dephosphorylation site |
KI2L1_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000336769 | R99I | BIOMART | Breast Cancer | 21930507, 21930502 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000336769 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 3 hour) | cell line | Up | 1.6 | 15169874 |
Hyperphosphorylation site |
KI2L1_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
1C18_HUMAN | KI2L1_HUMAN | ligand -> receptor | HPMR |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa05332 | Graft-versus-host disease |
hsa04612 | Antigen processing and presentation |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0004872 | receptor activity | TAS | molecular_function |
GO:0002769 | natural killer cell inhibitory signaling pathway | IDA | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0050776 | regulation of immune response | TAS | biological_process |
GO:0005887 | integral to plasma membrane | TAS | cellular_component |
GO:0006955 | immune response | TAS | biological_process |
GO:0005886 | plasma membrane | IDA | cellular_component |